目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global active pharmaceutical ingredients market (API) 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global active pharmaceutical ingredients market (API) 2018 - 2022 ($ billion)
4.2 Manufacturing Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Manufacturing Type Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Manufacturing Type
6.1 Market segments
Exhibit 30: Chart on Manufacturing Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Manufacturing Type - Market share 2023-2028 (%)
6.2 Comparison by Manufacturing Type
Exhibit 32: Chart on Comparison by Manufacturing Type
Exhibit 33: Data Table on Comparison by Manufacturing Type
6.3 Captive APIs - Market size and forecast 2023-2028
Exhibit 34: Chart on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Captive APIs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Captive APIs - Year-over-year growth 2023-2028 (%)
6.4 Contract APIs - Market size and forecast 2023-2028
Exhibit 38: Chart on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Contract APIs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Contract APIs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Manufacturing Type
Exhibit 42: Market opportunity by Manufacturing Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Manufacturing Type ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2023-2028 (%)
Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Innovative APIs - Market size and forecast 2023-2028
Exhibit 48: Chart on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Innovative APIs - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Innovative APIs - Year-over-year growth 2023-2028 (%)
7.4 Generic APIs - Market size and forecast 2023-2028
Exhibit 52: Chart on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Generic APIs - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Generic APIs - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ billion)
Exhibit 57: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Exhibit 63: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 China - Market size and forecast 2023-2028
Exhibit 79: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on China - Year-over-year growth 2023-2028 (%)
9.8 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.9 India - Market size and forecast 2023-2028
Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amneal Pharmaceuticals Inc.
Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
12.5 Aurobindo Pharma Ltd.
Exhibit 116: Aurobindo Pharma Ltd. - Overview
Exhibit 117: Aurobindo Pharma Ltd. - Product / Service
Exhibit 118: Aurobindo Pharma Ltd. - Key offerings
12.6 Cadila Pharmaceuticals Ltd.
Exhibit 119: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 120: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 121: Cadila Pharmaceuticals Ltd. - Key offerings
12.7 Cipla Ltd.
Exhibit 122: Cipla Ltd. - Overview
Exhibit 123: Cipla Ltd. - Business segments
Exhibit 124: Cipla Ltd. - Key news
Exhibit 125: Cipla Ltd. - Key offerings
Exhibit 126: Cipla Ltd. - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 131: GlaxoSmithKline Plc - Overview
Exhibit 132: GlaxoSmithKline Plc - Business segments
Exhibit 133: GlaxoSmithKline Plc - Key news
Exhibit 134: GlaxoSmithKline Plc - Key offerings
Exhibit 135: GlaxoSmithKline Plc - Segment focus
12.10 Koninklijke DSM NV
Exhibit 136: Koninklijke DSM NV - Overview
Exhibit 137: Koninklijke DSM NV - Business segments
Exhibit 138: Koninklijke DSM NV - Key news
Exhibit 139: Koninklijke DSM NV - Key offerings
Exhibit 140: Koninklijke DSM NV - Segment focus
12.11 Lupin Ltd.
Exhibit 141: Lupin Ltd. - Overview
Exhibit 142: Lupin Ltd. - Product / Service
Exhibit 143: Lupin Ltd. - Key news
Exhibit 144: Lupin Ltd. - Key offerings
12.12 Novartis AG
Exhibit 145: Novartis AG - Overview
Exhibit 146: Novartis AG - Business segments
Exhibit 147: Novartis AG - Key offerings
Exhibit 148: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 149: Pfizer Inc. - Overview
Exhibit 150: Pfizer Inc. - Product / Service
Exhibit 151: Pfizer Inc. - Key news
Exhibit 152: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 153: Sanofi SA - Overview
Exhibit 154: Sanofi SA - Business segments
Exhibit 155: Sanofi SA - Key news
Exhibit 156: Sanofi SA - Key offerings
Exhibit 157: Sanofi SA - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 158: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 159: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 160: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 166: Viatris Inc. - Overview
Exhibit 167: Viatris Inc. - Business segments
Exhibit 168: Viatris Inc. - Key news
Exhibit 169: Viatris Inc. - Key offerings
Exhibit 170: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global active pharmaceutical ingredients market (API) 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Manufacturing Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Manufacturing Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Manufacturing Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Manufacturing Type
Exhibits33: Data Table on Comparison by Manufacturing Type
Exhibits34: Chart on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Captive APIs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Captive APIs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Contract APIs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Contract APIs - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Manufacturing Type ($ billion)
Exhibits43: Data Table on Market opportunity by Manufacturing Type ($ billion)
Exhibits44: Chart on Type - Market share 2023-2028 (%)
Exhibits45: Data Table on Type - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Innovative APIs - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Innovative APIs - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Generic APIs - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Generic APIs - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Type ($ billion)
Exhibits57: Data Table on Market opportunity by Type ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amneal Pharmaceuticals Inc. - Overview
Exhibits112: Amneal Pharmaceuticals Inc. - Business segments
Exhibits113: Amneal Pharmaceuticals Inc. - Key news
Exhibits114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits116: Aurobindo Pharma Ltd. - Overview
Exhibits117: Aurobindo Pharma Ltd. - Product / Service
Exhibits118: Aurobindo Pharma Ltd. - Key offerings
Exhibits119: Cadila Pharmaceuticals Ltd. - Overview
Exhibits120: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits121: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits122: Cipla Ltd. - Overview
Exhibits123: Cipla Ltd. - Business segments
Exhibits124: Cipla Ltd. - Key news
Exhibits125: Cipla Ltd. - Key offerings
Exhibits126: Cipla Ltd. - Segment focus
Exhibits127: Dr Reddys Laboratories Ltd. - Overview
Exhibits128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits131: GlaxoSmithKline Plc - Overview
Exhibits132: GlaxoSmithKline Plc - Business segments
Exhibits133: GlaxoSmithKline Plc - Key news
Exhibits134: GlaxoSmithKline Plc - Key offerings
Exhibits135: GlaxoSmithKline Plc - Segment focus
Exhibits136: Koninklijke DSM NV - Overview
Exhibits137: Koninklijke DSM NV - Business segments
Exhibits138: Koninklijke DSM NV - Key news
Exhibits139: Koninklijke DSM NV - Key offerings
Exhibits140: Koninklijke DSM NV - Segment focus
Exhibits141: Lupin Ltd. - Overview
Exhibits142: Lupin Ltd. - Product / Service
Exhibits143: Lupin Ltd. - Key news
Exhibits144: Lupin Ltd. - Key offerings
Exhibits145: Novartis AG - Overview
Exhibits146: Novartis AG - Business segments
Exhibits147: Novartis AG - Key offerings
Exhibits148: Novartis AG - Segment focus
Exhibits149: Pfizer Inc. - Overview
Exhibits150: Pfizer Inc. - Product / Service
Exhibits151: Pfizer Inc. - Key news
Exhibits152: Pfizer Inc. - Key offerings
Exhibits153: Sanofi SA - Overview
Exhibits154: Sanofi SA - Business segments
Exhibits155: Sanofi SA - Key news
Exhibits156: Sanofi SA - Key offerings
Exhibits157: Sanofi SA - Segment focus
Exhibits158: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits159: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits160: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits162: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits164: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits166: Viatris Inc. - Overview
Exhibits167: Viatris Inc. - Business segments
Exhibits168: Viatris Inc. - Key news
Exhibits169: Viatris Inc. - Key offerings
Exhibits170: Viatris Inc. - Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations